Shuang Yang Selected Research

Shuang Yang Research Topics

Disease

61	Neoplasms (Cancer) 07/2022 - 11/2007
28	Breast Neoplasms (Breast Cancer) 03/2022 - 06/2007
17	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2007
10	Infections 02/2022 - 06/2014
7	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 10/2015
5	Inflammation (Inflammations) 10/2021 - 01/2014
5	Atherosclerosis 01/2021 - 01/2013
5	Pathologic Processes 01/2020 - 09/2013
4	Wounds and Injuries (Trauma) 10/2022 - 01/2018
4	Carcinogenesis 01/2022 - 02/2010
4	Leukemia 01/2022 - 01/2014
4	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2013
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2017
4	Thrombosis (Thrombus) 01/2019 - 03/2010
3	Adenocarcinoma of Lung 05/2022 - 10/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 04/2013
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2014
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 02/2015
3	COVID-19 11/2021 - 10/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 05/2013
3	Pain (Aches) 01/2021 - 01/2020
3	Body Weight (Weight, Body) 12/2019 - 01/2016
3	Osteoporosis 01/2017 - 09/2003
3	Necrosis 03/2015 - 11/2014
2	Stroke (Strokes) 04/2022 - 01/2022
2	Cognitive Dysfunction 04/2022 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 03/2022 - 01/2017
2	Hypersensitivity (Allergy) 01/2022 - 12/2017
2	Hypertension (High Blood Pressure) 01/2022 - 01/2017
2	Rupture 01/2022 - 11/2008
2	Periodontitis 01/2022 - 07/2008
2	Hypoxia (Hypoxemia) 01/2022 - 08/2014
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022 - 08/2018
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Disease Progression 01/2022 - 01/2021
2	Hyperglycemia 01/2022 - 12/2019
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 02/2021 - 08/2020
2	Critical Illness (Critically Ill) 12/2020 - 10/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 01/2014
2	Ulcerative Colitis 01/2020 - 03/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 02/2022 - 12/2010
14	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2014
11	Pharmaceutical PreparationsIBA 10/2022 - 01/2015
11	Glycoproteins (Glycoprotein)IBA 05/2022 - 01/2015
10	Bone Morphogenetic Protein 6IBA 03/2016 - 09/2003
8	Polysaccharides (Glycans)IBA 01/2022 - 04/2013
8	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2010
8	Transcription Factors (Transcription Factor)IBA 11/2020 - 02/2010
6	Messenger RNA (mRNA)IBA 01/2020 - 11/2007
5	Biological ProductsIBA 01/2022 - 01/2015
5	Long Noncoding RNAIBA 01/2021 - 12/2016
5	Zinc Finger E-box-Binding Homeobox 1IBA 11/2020 - 01/2016
5	LipidsIBA 03/2016 - 08/2010
4	CalciumIBA 01/2022 - 02/2014
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 11/2013
4	muskIBA 12/2018 - 01/2017
3	ChitosanIBA 10/2022 - 01/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2022 - 03/2011
3	Blood Proteins (Serum Proteins)IBA 02/2022 - 01/2021
3	Sialic AcidsIBA 01/2022 - 01/2017
3	CytokinesIBA 01/2022 - 08/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2014
3	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2020
3	CateninsIBA 01/2021 - 09/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 09/2015
3	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 10/2015
3	AndrogensIBA 01/2018 - 10/2015
3	Cadherins (E-Cadherin)IBA 04/2009 - 11/2007
3	Estrogens (Estrogen)FDA Link 04/2008 - 09/2003
2	SteroidsIBA 10/2022 - 06/2014
2	AutoantibodiesIBA 05/2022 - 01/2020
2	ProdrugsIBA 02/2022 - 12/2021
2	NucleotidesIBA 02/2022 - 01/2022
2	EnzymesIBA 01/2022 - 01/2018
2	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
2	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2015
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 12/2019
2	indacaterolIBA 01/2022 - 01/2020
2	ApolipoproteinsIBA 01/2022 - 01/2016
2	ChemokinesIBA 01/2022 - 01/2019
2	oxidized low density lipoproteinIBA 01/2022 - 01/2013
2	InflammasomesIBA 01/2022 - 01/2020
2	Type 2 Galanin ReceptorIBA 02/2021 - 01/2020
2	GalaninIBA 02/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2019
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2020
2	Advanced Glycation End ProductsIBA 12/2020 - 10/2019
2	Therapeutic UsesIBA 10/2020 - 01/2020
2	Lidocaine (Xylocaine)FDA LinkGeneric 10/2020 - 01/2018
2	Mupirocin (Bactroban)FDA LinkGeneric 10/2020 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2016

Therapy/Procedure

28	Therapeutics 03/2022 - 03/2010
8	Drug Therapy (Chemotherapy) 01/2021 - 02/2010
3	Aftercare (After-Treatment) 01/2021 - 11/2014
3	Stents 12/2012 - 03/2010